Symvivo Corporation
$2,821,081.00 CAD
≈ 36 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- September 4, 2020 – May 31, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q2-956763
Published purpose
The goal of this project is to develop and clinically evaluate an oral, room temperature stable DNA vaccine candidate for SARS-CoV2. The project will involve the advancement of the bacTRL-Spike COVID-19 vaccine candidate through preclinical development, process development manufacturing scale-up, and first-in-human clinical testing.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions